Review of novel and supplemental approvals of the targeted cancer drugs by the Food and Drug Administration in 2021.

Esin Aysel Kandemir

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Targeted cancer treatments are gaining more importance than ever in treating malignant diseases. As the approval of targeted cancer drugs provides a possibility for patients and this trend is expected to continue in the future, it remains vital for healthcare providers to stay up-to-date with newer therapeutic options.

Keyphrases

papillary thyroid
healthcare
squamous cell
drug administration
cancer therapy
end stage renal disease
ejection fraction
chronic kidney disease
lymph node metastasis
squamous cell carcinoma
childhood cancer
prognostic factors
climate change
patient reported outcomes
health insurance